Yahoo Finance Top Ranked Momentum Stocks to Buy for May 19th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 19th:
AgroFresh Solutions, Inc. (AGFS): This company that provides science-based solutions, data-driven technologies, and services to enhance the quality and extend the shelf life of fresh produce has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.2% over the last 60 days.
AgroFresh Solutions, Inc. Price and Consensus
AgroFresh Solutions, Inc. price-consensus-chart | AgroFresh Solutions, Inc. Quote
AgroFresh Solutions’ shares gained 67.1% over the last one month compared with the S&P 500 growth of 2.8%. The company possesses a Momentum Score of A.
AgroFresh Solutions, Inc. Price
AgroFresh Solutions, Inc. price | AgroFresh Solutions, Inc. Quote
United Natural Foods, Inc. (UNFI): This company that distributes natural, organic, specialty, produce, and conventional grocery and non-food products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.1% over the last 60 days.
United Natural Foods, Inc. Price and Consensus
United Natural Foods, Inc. price-consensus-chart | United Natural Foods, Inc. Quote
United Natural Foods’ shares gained 59.4% over the last one month. The company possesses a Momentum Score of B.
United Natural Foods, Inc. Price
United Natural Foods, Inc. price | United Natural Foods, Inc. Quote
Milestone Pharmaceuticals Inc. (MIST): This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
Milestone Pharmaceuticals Inc. Price and Consensus
Milestone Pharmaceuticals Inc. price-consensus-chart | Milestone Pharmaceuticals Inc. Quote
Milestone Pharmaceuticals’ shares gained 40.1% over the last one month. The company possesses a Momentum Score of B.
Milestone Pharmaceuticals Inc. Price
Milestone Pharmaceuticals Inc. price | Milestone Pharmaceuticals Inc. Quote
Syros Pharmaceuticals, Inc. (SYRS): This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
Syros Pharmaceuticals, Inc. Price and Consensus
Syros Pharmaceuticals, Inc. price-consensus-chart | Syros Pharmaceuticals, Inc. Quote
Syros Pharmaceuticals’ shares gained 12.7% over the last one month. The company possesses a Momentum Score of A.
Syros Pharmaceuticals, Inc. Price
Syros Pharmaceuticals, Inc. price | Syros Pharmaceuticals, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
United Natural Foods, Inc. (UNFI) : Free Stock Analysis Report
Syros Pharmaceuticals, Inc. (SYRS) : Free Stock Analysis Report
Milestone Pharmaceuticals Inc. (MIST) : Free Stock Analysis Report
AgroFresh Solutions, Inc. (AGFS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
